KLK3 and prostate cancer: In addition, similar analyses from comparable trials of organised screening could provide illuminating corroboration or contradiction of the findings presented here, because we are not aware of any other published analyses of mortality from causes other than prostate cancer among diagnosed men in trials of PSA mass screening for prostate cancer [47].